John McCoy
President chez CARDIOVASCULAR SYSTEMS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
John A.
McCoy is currently the President & Treasurer at Cardiovascular Systems, Inc. He also holds the position of Vice President-Finance & Controller at Abbott Laboratories, starting in 2018.
Previously, he served as the Senior Vice President & Controller at Baxalta, Inc. from 2015 to 2016.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ABBOTT LABORATORIES
0,00% | 01/03/2024 | 18 816 ( 0,00% ) | 2 M $ | 31/03/2024 |
Postes actifs de John McCoy
Sociétés | Poste | Début |
---|---|---|
CARDIOVASCULAR SYSTEMS, INC. | President | - |
ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 01/09/2023 |
Anciens postes connus de John McCoy
Sociétés | Poste | Fin |
---|---|---|
BAXALTA INC | Comptroller/Controller/Auditor | 01/01/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Entreprise privées | 2 |
---|---|
Baxalta, Inc.
Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. | Health Technology |